HomeNews

News

Global Markets

Merck KGaA expects adjusted profit to rise to 9% due to demand for laboratory products

Pharma -
Germany's Merck KGaA said it expects earnings growth of up to 9% this year, mainly driven by drugmakers' demand for its laboratory gear business,...
Global Markets

Yale, JDRF and NexImmune, $600,000 grant for diabetes research

Pharma -
NexImmune, Inc., Yale and JDRF have begun a two-year project to explore the use of NexImmune’s AIM nanoparticles in combination with an anti-CD3 mAb...
Global Markets

Roche’s 2nd cancer immunotherapy trial fails, shares down the most in a year

Pharma -
Development of a new cancer treatment pioneered by Roche was thrown into doubt on Wednesday when the immunotherapy drug failed to slow progression of...
Global Markets

Bavarian Nordic starts share buy-back program

Pharma -
Bavarian Nordic A/S May 9th announced the initiation of a new share buy-back program, under which the Company intends to buy back up to...
Drug Development

FDA lifts ban on LogicBio’s clinical trial on pediatric patients with methylmalonic acidemia

Pharma -
LogicBio Therapeutics, Inc., a clinical-stage company advancing a diversified pipeline of genetic medicines addressing rare disorders from infancy through adulthood, May 9th announced that...
AI in Pharma

AbbVie and Cerebras collaborate to accelerate artificial intelligence biopharmaceutical research

Pharma -
Cerebras Systems, the pioneer in high performance artificial intelligence (AI) computing, and AbbVie, a global biopharmaceutical company, announced a landmark achievement in AbbVie’s AI...
1...303132...118Page 31 of 118
spot_img

Expert Articles

spot_img